H. pylori infection: Bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome

Critical Reviews in Clinical Laboratory Sciences

Volumn 41, Issue 3, 2004, Pages 313-337

  Basso, Daniela ^a   Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

cagA; Cytokines; Gastric adenocarcinoma; Gastritis; Gene polymorphism; H. pylori

Indexed keywords

ADHESIN; CAGA PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UREASE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST; HUMAN; MUCOSA INFLAMMATION; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; STOMACH MUCOSA LESION;

ANIMALS; CYTOKINES; DISEASE PROGRESSION; GASTRITIS; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; POLYMORPHISM, GENETIC; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; NEGIBACTERIA; SABA;

EID: 3042831517     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360490472804     Document Type: Review

References (141)

1. Morris Brown L. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 2000; 22: 283-97.
2. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-41.
3. Montecucco C, Rappuoli R. Living dangerously: How Helicobacter pylori survives in the human stomach. Nature Rev Mol Cell Biol 2001; 2: 457-66.
4. Plebani M, Basso D, Cassaro M, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996; 91: 954-8.
5. Warburton VJ, Everett S, Mapstone NP, et al. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998; 51: 55-61.
6. Zambon C-F, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and sl vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003; 56: 287-91.
7. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-9.
8. Navaglia F, Basso D, Piva MG, et al. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am J Gastroenterol 1998; 93: 227-30.
9. Basso D, Navaglia F, Brigato L, et al. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 1998; 43: 182-6.
10. Yamaoka Y, Kodama T, Gutierrez O, et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different countries. J Clin Microbiol 1999; 37: 2274-9.
11. Infection with Helicobacter pylori. In: IARC monographs on the evaluation of the carcinogenetic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994: 177-241.
12. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric adenocarcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
13. Hirai M, Azuma T, Ito S, et al. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994; 56: 56-60.
14. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
15. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
16. Keates S, Keates AC, Warny M, et al. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol 1999; 163: 5552-9.
17. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogens c-fos and c-jun. J Biol Chem 2000; 275: 16064-72.
18. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-2.
19. Peek RM Jr, Moss SF, Tham KT, et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 863-8.
20. Peek RM Jr. Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: Implications for carcinogenesis. J Gastroenterol 2002; 37(Suppl 13): 10-6.
21. Ho SB. Premalignant lesions of the stomach. Sem Gastrointest Dis 1996; 7: 61-73.
22. Bergin JJL, Sheppard BJ, Fox JG. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis Sci 2003; 48: 475-85.
23. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
24. Murakami K, Fujioka T, Kodama R, et al. Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastreonterol 1997; 32: 184-8.
25. Rieder G, Hofmann JA, Hatz RA, Stolte M, Enders GA. Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol 2003; 293: 403-12.
26. Baik S-C, Youn H-S, Chung M-H, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996; 56: 1279-82.
27. Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenensis. Gut 1998; 42: 351-6.
28. Farinati F, Cardin R, Russo VM, et al. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: A potential pathway to cancer? Helicobacter 2003; 8: 227-34.
29. Basso D, Scrigner M, Toma A, et al. Helicobacter pylori infection enhances mucosal interleukin-1, interleukin-6, and the solubile receptor of interleukin-2. Int J Clin Lab Res 1996; 26: 207-10.
30. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm A-M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-71.
31. Zambon C-F, Basso D, Navaglia F, et al. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002; 18: 242-51.
32. Holck S, Norgaard A, Bennedsen M, et al. Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacterial load. FEMS Immunol Med Microbiol 2003; 36: 175-80.
33. Bontems P, Robert F, Van Gossum A, Cadranel S, Mascart F. Helicobacter pylori modulation of gastric and duodenal mucosal T cell cytokine secretion in children compared with adults. Helicobacter 2003; 8: 216-26.
34. El-Omar EM, Carrington M, Chow W-H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
35. El-Omar EM, Carrington M, Chow W-H, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412: 99.
36. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-9.
37. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-7.
38. Furuta T, El-Omar EM, Xiao F, et al. Interleukin 1β polymorphisms increase risk of hypochloridria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105.
39. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-71.
40. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-201.
41. Zeng Z-R, Hu P-J, Hu S, et al. Association of interleukin 1B gene polymorphisms and gastric cancers in high and low prevalence regions in China. Gut 2003; 52: 1684-9.
42. Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995; 59: 451-80.
43. Marais A, Mendz GL, Hazell SL, Mégraud F. Metabolism and genetics of Helicobacter pylori. The genome era. Microbiol Mol Biol Rev 1999; 63: 642-74.
44. Voland P, Weeks DL, Marcus EA, et al. Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster. Am J Physiol Gastrointest Liver Physiol 2003; 284: G96-106.
45. Scott DR, Weeks D, Hong C, et al. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 1998; 114: 58-70.
46. Dunn BE, Phadnis SH. Structure, function and localization of Helicobacter pylori urease. Yale J Biol Med 1998; 71: 63-73.
47. Sachs G, Shin JM, Munson K, et al. Review article: The control of gastric acid and Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 1383-401.
48. Sachs G, Shin JM, Vagin O, et al. Current trends in treatment of upper gastrointestinal disease. Best Pract Res Clin Gastroenterol 2002; 16: 835-49.
49. Hong W, Sano K, Morimatsu S, et al. Medium pH-dependent redistribution of the urease of Helicobacter pylori. J Med Microbiol 2003; 52: 211-6.
50. Stingl K, Altendorf K, Bakker EP. Acid survival of Helicobacter pylori: How does urease activity trigger cytoplasmic pH homeostasis? Trends Microbiol 2002; 10: 70-4.
51. Tanahashi T, Kita M, Kodama T, et al. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect Immun 2000; 68: 664-71.
52. Berger A. Helicobacter pylori breath test. Br Med J 2002; 324: 1263.
53. Basso D, Navaglia F, Cassaro M, et al. Gastric juice polymerase chain reaction: An alternative to histology in the diagnosis of Helicobacter pylori infection. Helicobacter 1996; 1: 159-64.
54. 13C-urea breath test, stool antigen testing or DNA PCR in human faeces in a clinical laboratory setting? Clin Biochem 2004, 37: 261-7.
55. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998; 36: 2258-63.
56. Yamaoka Y, El-Zimaity HM, Gutierrez O, et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999; 117: 342-9.
57. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
58. Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med 2000; 191: 587-92.
59. Salama N, Guillemin K, McDaniel TK, et al. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci USA 2000; 97: 14668-73.
60. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered state: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-64.
61. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-8.
62. Cox JM, Clayton CL, Tomita T, et al. cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun 2001; 69: 6970-80.
63. Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99: 14428-33.
64. Guillemin K, Salama NR, Tompkins LS, Falkow S. cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci USA 2002; 99: 15136-41.
65. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-6.
66. Higashi H, Nakaya A, Tsutsumi R, et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-16.
67. Choi U, Kim JS, Kim JM, Jung HC, Song IS. Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun 2003, 71: 830-7.
68. Hirata Y, Maeda S, Mitsuno Y, et al. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology 2002; 123: 1962-71.
69. Amieva MR, Vogelmann R, Covacci A, et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-4.
70. Moss SF, Sordillo EM, Abdalla AM, et al. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains. Cancer Res 2001; 61: 1406-11.
71. Selbach M, Moese S, Mayer TF, Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002; 70: 665-71.
72. Sharma SA, Tummuru MKR, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kB in gastric epithelial cells. J Immunol 1998; 160: 2401-7.
73. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001; 15: 1271-90.
74. Papini E, Zoratti M, Cover TL. In search of the Helicobacter pylori VacA mechanism of action. Toxicon 2001; 39: 1757-67.
75. Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003; 5: 715-21.
76. Cover TL, Krishna US, Israel DA, Peek RM. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003; 63: 951-7.
77. Supajatura V, Ushio H, Wada A, et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168: 2603-7.
78. Plebani M, Basso D, Busatto G, et al. Are tryptase and cathepsin D related to Helicobacter pylori infection and mucosal gastrin in peptic ulcer? Res Exp Med 1994; 194: 1-8.
79. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301: 1099-1102.
80. Yamaoka Y, Kwon DH, Graham DY. A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000; 97: 7533-8.
81. Yamaoka Y, Kikuchi S, El-Zimaity HMT, et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002; 123: 414-24.
82. Coskun T, Chu S, Montrose MH. Intragastric pH regulates conversion from net acid to net alkaline secretion by the rat stomach. Am J Physiol Gastrointest Liver Physiol 2001; 281: G870-7.
83. Coskun T, Baumgartner HK, Chu S, Montrose MH. Coordinated regulation of gastric chloride secretion with both acid and alkali secretion. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1147-55.
84. Baumgartner HK, Montrose MH. Regulated alkali secretion acts in tandem with unstirred layers to regulate mouse gastric surface pH. Gastroenterology 2004; 126: 774-83.
85. Evans DJ, Evans DG. Helicobacter pylori adhesins: Review and perspectives. Helicobacter 2000; 5: 183-95.
86. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-7.
87. Prinz C, Schoniger M, Rad R, et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001; 61: 1903-9.
88. Yamaoka Y, Souchek J, Odenbreit S, et al. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 2002; 40: 2244-6.
89. Yu J, Leung WK, Go MYY, et al. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002; 51: 480-4.
90. Mahdavi J, Sondén B, Hurting M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297: 573-8.
91. Sheu B-S, Sheu S-M, Yang H-B, Huang A-H, Wu J-J. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 2003; 52: 927-32.
92. Cao P, Cover TL. Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol 2002; 40: 4504-11.
93. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
94. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 2000; 68: 4802-4.
95. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nature Med 2002; 8: 567-73.
96. Bauditz J, Ortner M, Bierbaum M, et al. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 1999; 117: 316-23.
97. Hida N, Shimoyama Jr T, Neville P, et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: Relation to bacterial cag status and peptic ulceration. J Clin Pathol 1999; 52: 658-64.
98. Guiney DG, Hasegawa P, Cole SP. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 2003; 71: 4163-6.
99. Weigmann B, Neurath MF. T-bet and mucosal Th1 responses in the gastrointestinal tract. Gut 2002; 51: 301-3.
100. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev Immunol 2003; 3: 133-46.
101. D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158: 962-67.
102. Akhiani AA, Pappo J, Kabok Z, et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 2002; 169: 6977-84.
103. Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumor necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999; 8: 1443-9.
104. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000; 61: 863-6.
105. Hacker UT, Erhardt S, Tschop K, Jelinek T, Endres S. Influence of the IL-1Ra polymorphism on in vivo synthesis of the IL-1Ra and IL-1β after live yellow fever vaccination. Clin Exp Immunol 2001; 125: 465-9.
106. Hwang I-R, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803.
107. Furuta T, Shirai N, Takashima M, Xiao F, Sugimura H. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am J Med 2002; 112: 141-3.
108. Hoogendoorn B, Coleman SL, Guy CA, et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet 2003; 12: 2249-54.
109. Zambon C-F, Basso D, Navaglia F, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2004; 126: 382-3.
110. Ando T, Kusugami K, Ohsuga M, et al. Mucosal macrophage inflammatory protein-1α levels are increased in Helicobacter pylori infection. J Clin Gastroenterol 1998; 27(Suppl. 1): S144-9.
111. Nozawa Y, Nishihara K, Peek RM, et al. Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem Pharmacol 2002; 64: 21-30.
112. El-Omar EM. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 2001; 48: 743-7.
113. Beales ILP. Effect of interleukin-1β on proliferation of gastric epithelial cells in culture. BMC Gastroenterology 2002; 2: 7.
114. Beales HP, Calam J. Interleukin 1β and tumour necrosis factor a inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-34.
115. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 48: 765-73.
116. Mahr S, Neumayer N, Gerhard M, et al. IL-1 beta-induced apoptosis in rat gastric enterochromaffin-like cells is mediated by iNOS, NK-kappaB, and Bax protein. Gastroenterology 2000; 118: 515-24.
117. Weigert N, Schaffer K, Schusdziarra V, et al. Gastrin secretion from primary cultures of rabbit antral G cells: Stimulation by inflammatory cytokines. Gastroenterology 1996; 110: 147-54.
118. Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion - a little goes a long way. Gastroenterology 1992; 102: 2177-8.
119. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323-40.
120. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002; 13: 135-41.
121. Thalmaier U, Lehn N, Pfeffer K, et al. Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice. Infect Immun 2002; 70: 3149-55.
122. van den Brink GR, ten Kate FJ, Ponsioen CY, et al. Expression and activation of NF-kB in the antrum of the human stomach. J Immunol 2000; 164: 3353-9.
123. Huber C, Zanner R, Pohlinger A, et al. Tumor necrosis factor-alpha effects on rat gastric enterochromaffin-like cells. Digestion 2002; 65: 87-102.
124. Beales ILP, Post L, Calam J, Yamada T, Del Valle J. Tumor necrosis factor alpha stimulates gastrin release from canine and human antral G cells: Possible mechanism of the Helicobacter pylori-gastrin link. Eur J Clin Invest 1996; 26: 609-11.
125. Kunstmann E, Epplen C, Elitok E, et al. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999; 20: 1756-61.
126. Yea SS, Yang Y-I, Jang WH, et al. Association between TNF-α promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-6.
127. Jang WH, Yang Y-I, Yea SS, et al. The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001; 166: 41-6.
128. Knight JC, Udalova I, Hill AVS, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-50.
129. Hohjoh H, Tokunaga K. Allele specific binding of ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001; 2: 105-9.
130. van Heel DA, Udalova IA, De Silva AP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Hum Mol Genet 2002; 11: 1281-9.
131. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000; 12: 110-19.
132. de Jong BA, Westendorp RGJ, Bakker AM, Huizinga TWJ. Polymorphisms in or near tumor necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production. Genes Immun 2002; 3: 25-9.
133. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 2001; 4: 251-9.
134. Sawai N, Kita M, Kodama T, et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999; 67: 279-85.
135. Obonyo M, Guiney DG, Harwood J, Fierer J, Cole SP. Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection. Infect Immun 2002; 70: 3295-9.
136. Thye T, Burchard GD, Nilius M, Muller-Myhsok B, Horstmann RD. Genome-wide linkage analysis identifies polymorphisms in the human interferon-g receptor affecting Helicobacter pylori infection. Am J Hum Genet 2003; 72: 448-53.
137. Julinger S, Bongartz M, Luty AJF, Kremsner PG, Kun JFJ. Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 2003; 54: 675-80.
138. Chen W, Shu D, Chadwick S. Helicobacter pylori infection: Mechanism of colonization and functional dyspepsia. Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 2001; 16: 377-83.
139. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
140. Hwang I-R, Hsu P-I, Peterson LE, et al. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003; 8: 142-8.
141. Hamajima N, Katsuda N, Matsuo K, et al. High anti-Helicobacter pylori antibody seropositivity associated with a combination of IL-8-251 TT and IL-10-819 TT genotypes. Helicobacter 2003; 8: 105-10.